|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.40 EUR | +0.65% |
|
+6.94% | +5.48% |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | ||
| 833.31 | +36.62% | 28 | ||||||
| 292.44 | +17.12% | 18 | ||||||
| 2,096,122.22 | +52.56% | 23 | ||||||
| 96.75 | +18.64% | 16 | ||||||
| 220.25 | +12.04% | 31 | ||||||
| 43.3 | -32.3% | 20 | ||||||
| 109.35 | +11.33% | 23 | ||||||
| 101.64 | +54.41% | 26 | ||||||
| 471.67 | +7.15% | 12 | ||||||
| 102.28 | +54.34% | 23 | ||||||
| 276.47 | +10.37% | 21 | ||||||
| 458,000 | +29.56% | 5 | ||||||
| 87.85 | +60.63% | 26 | ||||||
| 339.22 | -2.54% | 9 | ||||||
| 14.4 | +58.16% | 12 | ||||||
| 71.1 | -18.8% | 10 | ||||||
| - | - | 40.3 | +41.21% | 1 | ||||
| - | - | 61.5 | +53.17% | 1 | ||||
| 31.4 | +124% | 10 | ||||||
| Average | 134,595.55 | +30.93% | 17 | ||||||
| Weighted average by Cap. | 237,663.32 | +25.94% | 20 |
- Stock Market
- Stocks
- ZLAB Stock
- 1ZL Stock
- Sector Zai Lab Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
